MedPath
NMPA Approval

Tafluprost Eye Drops

国药准字H20243690

May 15, 2024

Drug Information

他氟前列素滴眼液

眼用制剂

0.0015%(0.3ml:4.5μg)

化学药品

May 15, 2024

Company Information

Applicant Company

泰州市扬子江南路1号

Manufacturing Company

江苏省泰州市扬子江南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟前列素滴眼液 - NMPA 批准文号 | MedPath